hit counter

Lisdexamfetamine (Vyvanse) Changes Brain Connectivity & Activation to Treat Binge Eating Disorder (2023 Study)

Binge-eating disorder (BED), characterized by recurrent episodes of overeating without compensatory behaviors, is a significant global health concern. Lisdexamfetamine dimesylate (LDX), the only drug approved for moderate to severe BED, is showing promise not just in reducing episodes but also in altering brain function in ways previously not fully understood. Through a groundbreaking study, researchers …

Read more

Vyvanse Approved For Binge Eating Disorder: How It Works, Benefits, & Risks

As of February 2015, the FDA approved the psychostimulant Vyvanse (Lisdexamfetamine) for the treatment of binge eating disorder. In recent years, the popularity of Vyvanse has skyrocketed as an ADHD medication, as well as among those seeking to use it for ulterior purposes such as weight loss, academics, and sports performance. Many consider the medication …

Read more